Get started
Author

Hayley McKie

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial
2022 · Paul R Kalra, John G F Cleland, et al. · The Lancet · 402
PDF
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 324
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
2023 · Erola Pairo-Castineira, Konrad Rawlik, et al. · Nature · 224
PDF
Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis
2024 · Joel M. Dulhunty, Stephen J. Brett, et al. · JAMA · 172
PDF
Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Myocardial Fibrosis
2024 · Krithika Loganath, Neil J. Craig, et al. · JAMA · 158
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 129
A second update on mapping the human genetic architecture of COVID-19
2023 · The COVID-19 Host Genetics Initiative, Leadership, et al. · Nature · 118
PDF
Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial
2024 · John G F Cleland, Philip A Kalra, et al. · European Heart Journal · 42
PDF
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39
PDF
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12
PDF
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2024 · RECOVERY Collaborative Group, Peter Sandercock, et al. · Nature Communications · 11
PDF
Impact of anthropometric factors on outcomes in atrial fibrillation patients: analysis on 10 220 patients from the European Society of Cardiology (ESC)-European Heart Rhythm Association (EHRA) EurObservational Research Programme on Atrial Fibrillation (EORP-AF) general long-term registry
2022 · Giuseppe Boriani, Marco Vitolo, et al. · European Journal of Preventive Cardiology · 10
PDF
Author Correction: GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
2023 · Erola Pairo-Castineira, Konrad Rawlik, et al. · Nature · 9
PDF
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O. Abani, A. Abbas, et al. · EClinicalMedicine · 5
The Impact of Ferric Derisomaltose on Cardiovascular and Noncardiovascular Events in Patients With Anemia, Iron Deficiency, and Heart Failure With Reduced Ejection Fraction
2023 · Robin Ray, Ian Ford, et al. · Journal of Cardiac Failure · 5
Myocardial Fibrosis and Early Intervention in Asymptomatic Patients With Severe Aortic Stenosis
2026 · Neil J. Craig, Krithika Loganath, et al. · JAMA Cardiology · 2
Assessing the Heartfelt Device's Predictive Value in Heart Failure Management: Findings from the Multicenter FOOT Trial (UK)
2024 · Matthew Dewhurst, Karen Hann, et al. · Heart & Lung · 2
The Foot Study, Observational Retrospective Multi-center Clinical Trial Evaluating Alerts From The Heartfelt Device
2024 · Matthew Dewhurst, Karen Hann, et al. · Journal of Cardiac Failure · 2
Evaluating Heartfelt’s predictive utility in heart failure: insights from the FOOT multicentre trial
2026 · Matthew Dewhurst, Karen Hann, et al. · BMJ Innovations
PDF
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases
PDF
3-005 Assessing the predictive capabilities of an AI-device in heart failure: a heart failure nurse’s perspective from a UK multi-centre trial
2025 · Karen Hann, Matthew Dewhurst, et al.
PDF
Works count: 23
Citation count: 1,705
H-index: 11
I10-index: 13
Year
Topic
Type